RxAnte Revenue and Competitors
Estimated Revenue & Valuation
- RxAnte's estimated annual revenue is currently $11.8M per year.
- RxAnte's estimated revenue per employee is $140,000
- RxAnte's total funding is $25.1M.
Employee Data
- RxAnte has 84 Employees.
- RxAnte grew their employee count by 17% last year.
RxAnte's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder & SVP, Chief Analytics Officer | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Chief Revenue Officer, RxAnte | Reveal Email/Phone |
4 | VP Data Services | Reveal Email/Phone |
5 | VP, IT Operations & Information Security Officer | Reveal Email/Phone |
6 | SVP, Client Success | Reveal Email/Phone |
7 | VP, Pharmacy Technology | Reveal Email/Phone |
8 | SVP, Head Technology Operations | Reveal Email/Phone |
9 | VP, Data Science | Reveal Email/Phone |
10 | SVP, General Counsel & Chief Privacy Officer | Reveal Email/Phone |
RxAnte Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11.8M | 84 | 17% | $25.1M | N/A |
What Is RxAnte?
Four out of five physician visits end with a prescription being written. Yet for many patients with chronic conditions, complications arise, health deteriorates, and costs spiral – all because potentially effective medications are not taken as prescribed. At RxAnte, we are passionate about improving health care, and we believe improving medication adherence is the most valuable place to start. RxAnte offers a new approach to improving population-level medication adherence efficiently. Born from decades of academic research, the RxAnte Solution is a patent-pending suite of analytics that: :Predicts medication adherence at the patient level ex ante (as early as the first filled prescription) :Prioritizes and targets the most cost-effective intervention(s) available for each patient :Monitors and evaluates the effectiveness of adherence programs :Measures and targets savings opportunities
keywords:Healthcare
$25.1M
Total Funding
84
Number of Employees
$11.8M
Revenue (est)
17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
RxAnte News
RxAnte, Inc., a McLean, VA-based health care improvement company providing a new and innovative approach for improving medication adherence, has raised a Series A financing. The round – whose amount was not disclosed – was led by Aberdare Ventures, with participation from the West Health Invest ...
Other Companies in Portland
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $27.3M | 84 | 18% | $19.5M |
#2 | $24.1M | 84 | 2% | N/A |
#3 | $27.1M | 84 | 62% | N/A |
#4 | $35M | 84 | 42% | N/A |
#5 | $12.3M | 85 | 9% | N/A |